Literature DB >> 573556

Pigmentary degeneration of the retina in the Hallervorden-Spatz syndrome.

F W Newell, R O Johnson, P R Huttenlocher.   

Abstract

Dizygotic twins developed a progressive neurologic disorder at age 6 months. When examined at age 7 1/2 years each had spastic quadriparesis and dystonia. Neither had ever spoken a complete sentence. The fundi showed bone spicule formation, a conspicuous choroidal circulation, and a striking accumulation of yellowish-white globular masses of varying sizes and shapes. Because our patients developed both the pigmentary degeneration and clinical signs of Hallervorden-Spatz syndrome at a much younger age than patients without retinopathy, we believe this case demonstrated a distinct nosologic entity.

Entities:  

Mesh:

Year:  1979        PMID: 573556     DOI: 10.1016/0002-9394(79)90648-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life.

Authors:  L Angelini; N Nardocci; V Rumi; C Zorzi; L Strada; M Savoiardo
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

Review 2.  Neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

3.  Clinicopathologic correlation and pathogenesis of ocular and central nervous system manifestations in Hallervorden-Spatz syndrome.

Authors:  R C Tripathi; B J Tripathi; S C Bauserman; J K Park
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 4.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

Review 5.  Iron homeostasis and toxicity in retinal degeneration.

Authors:  Xining He; Paul Hahn; Jared Iacovelli; Robert Wong; Chih King; Robert Bhisitkul; Mina Massaro-Giordano; Joshua L Dunaief
Journal:  Prog Retin Eye Res       Date:  2007-08-11       Impact factor: 21.198

6.  Retinal iron homeostasis in health and disease.

Authors:  Delu Song; Joshua L Dunaief
Journal:  Front Aging Neurosci       Date:  2013-06-28       Impact factor: 5.750

Review 7.  Potential Treatment of Retinal Diseases with Iron Chelators.

Authors:  Wanting Shu; Joshua L Dunaief
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.